Welcome to our dedicated page for Scientific Ind news (Ticker: SCND), a resource for investors and traders seeking the latest updates and insights on Scientific Ind stock.
Scientific Industries (SCND) delivers innovative benchtop laboratory equipment and digitally integrated bioprocessing systems for global research institutions. This news hub provides investors and industry professionals with centralized access to corporate developments, operational milestones, and technological advancements.
Track official press releases covering earnings results, product launches like the DOTS sensor platform, and strategic partnerships. Discover updates on manufacturing innovations, research collaborations, and regulatory achievements shaping the life sciences sector.
Our curated news collection enables efficient monitoring of SCND's progress in synthetic biology instrumentation and process optimization solutions. Bookmark this page for real-time updates on operational expansions, leadership announcements, and patent developments impacting laboratory efficiency.
Scientific Industries, Inc. (OTCQB:SCND) announced its financial results for the six-month transition period ended December 31, 2022, highlighting a 9% decline in net revenues to $5.2 million compared to the previous year. The company launched its VIVID Lite pill counter and reported a 20% increase in unit sales of the VIVID line. However, gross profit decreased to $2.3 million (44.2% margin) from $2.9 million (50.7% margin) due to the loss of royalty income. Total operating expenses rose slightly to $6.4 million, leading to a net loss of $4.08 million ($0.58 per share). The company underwent a restatement of previous financial statements, clarifying that these adjustments had no impact on cash flows or operations.